A full list of publications is accessible at: ORCID 0000-0003-2672-5766.
2022
Chaudhry S, Zurbriggen R, Preza M, Kämpfer T, Kaethner M, Memedovski R, Scorrano N, Hemphill A, Doggett JS, Lundström-Stadelmann B. Dual inhibition of the Echinococcus multilocularis energy metabolism. Frontiers in Veterinary Science. 2022 Aug 5;9:981664. doi: 10.3389/fvets.2022.981664.
Ilic N, Bojic Trbojevic Z, Lundström-Stadelmann B, Cujic D, Radovic I, Gruden-Movsesijan A. Immunomodulatory components of Trichinella spiralis excretory-secretory products with lactose-binding specificity. EXCLI Journal. Vol 21 (2022). https://doi.org/10.17179/excli2022-4954.
Weingartner M, Stücheli S, Jebbawi F, Gottstein B, Beldi G, Lundström-Stadelmann B, Wang J, Odermatt A. Albendazole reduces hepatic inflammation and endoplasmic reticulum-stress in a mouse model of chronic Echinococcus multilocularis infection. PLoS NTD. 2022 Jan 14;16(1):e0009192. doi: 10.1371/journal.pntd.0009192.
Frey CF, Basso WU, Zürcher-Giovanni S, Marti I, Borel St, Guthruf S, Gliga D, Lundström-Stadelmann B, Origgi FC, Ryser Degiorgis MP. The golden jackal (Canis aureus): A new host for Echinococcus multilocularis and Trichinella britovi in Switzerland. Schweiz Arch Tierheilkd. 2022 Jan;164(1):71-78. doi: 10.17236/sat00338.
2021
Karpstein T*, Chaudhry S*, Bresson-Hadni S, Hayoz, M, Boubaker G, Hemphill, A, Rufener R, Schindler I, Aebi Y, Largiader C, Lundström-Stadelmann B. Maca against echinococcosis? - A reverse approach from patient to in vitro drug testing. Pathogens. 2021 Oct 15;10(10):1335. doi: 10.3390/pathogens10101335.
Basso WU, Marreros N, Hofmann L, Salvisberg C, Lundström-Stadelmann B, Frey CF. Evaluation of the PrioCHECK™ Trichinella AAD kit to detect Trichinella spiralis, T. britovi, and T. pseudospiralis larvae in pork using the automated digestion method Trichomatic-35. Parasitol Int. 2021 Sep 2;86:102449. doi: 10.1016/j.parint.2021.102449.
Gomez C, Jebbawi F, Weingartner M, Wang J, Stücheli S, Stieger B, Gottstein B, Beldi G, Lundström-Stadelmann B, Odermatt, A. Impact on serum bile acid concentrations by alveolar echinococcosis and treatment with albendazole in mice. Metabolites. 2021 Jul 6;11(7):442. doi: 10.3390/metabo11070442.
Hemphill A, Lundström-Stadelmann B. Echinococcus - the model cestode parasite. Parasitology. Editorial. doi.org/10.1017/S003118202100113X.
Jebbawi F, Bellanger A-P, Lundström-Stadelmann B, Rufener R, Dosch M, Goepfert C, Gottstein B, Millon L, Gradgirard D, Leib SL, Beldi G, Wang J. Innate and adaptive immune responses following PD-L1 blockade in treating chronic murine alveolar echinococcosis. Parasite Immunol. 2021 Mar 23;e12834. doi: 10.1111/pim.12834.
2020
Wang J, Marreros N, Rufener R, Hemphill A, Gottstein B, Lundström-Stadelmann B. Efficacy of albendazole against alveolar echinococcosis is depending on the immune system. Exp Parasitol. Oct 2020: 219:108013. doi: 10.1016/j.exppara.2020.108013.
Lundström-Stadelmann B, Rufener R, Hemphill A. Drug repurposing applied: activity of the anti-malarial mefloquine against Echinococcus multilocularis. Int. J. Parasitol. Drugs Drug Resist. Aug 2020: Vol 13, 121-129. https://doi.org/10.1016/j.ijpddr.2020.06.002
Vural G, Yardimci M, Kocak M, Yasar TÖ, Kurt A, Harem IS, Carradori S, Sciamanna I, Siles-Lucas M, Fabiani M, Hemphill A, Lundström-Stadelmann B, Cirilli R, Casulli A. Efficacy of novel albendazole salt formulations against secondary cystic echinococcosis in experimentally infected mice. Parasitology. 2020, Jul 30; 1-8. doi: 10.1017/S0031182020001225.
Ritler, D., Marreros, N., Lundström-Stadelmann, B., 2020. IC50. Github.
2019
Ritler D, Rufener, R, Li JV, Kämpfer U, Müller J, Bühr C, Schürch S, Lundström-Stadelmann B. In vitro metabolomic footprint of the Echinococcus multilocularis metacestode. Sci Rep. 2019 Dec 19;9(1):19438. doi: 10.1038/s41598-019-56073-y.
Hemphill A, Rufener R, Ritler D, Dick L, Lundström-Stadelmann B. Drug Discovery and Development for the Treatment of Echinococcosis, Caused by the Tapeworms Echinococcus granulosus and Echinococcus multilocularis. In: Neglected Tropical Diseases: drug discovery and development (ed, David C Swinney, Michael Pollastri). 2019, pp. 251-286. Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany.
Frey C, Jenkins E, Lundström-Stadelmann B. Editorial overview: From farms and forests to forks? A review of diagnosis and management of globally important zoonotic Echinococcus spp. cestodes. FAWPAR. Volume 16, Sept 2019. doi.org/10.1016/j.fawpar.2019.e00061.
Hizem A, Lundström-Stadelmann B, M’rad S, Souier S, Jannet HB, Flamini G, Ghedira K, Babba H, Hemphill A. In vitro activity of Thymus capitatus essential oil against Echinococcus multilocularis metacestodes. Parasitology. Apr 12:1-12. doi: 10.1017/S0031182019000295.
Lundström-Stadelmann B, Rufener R, Ritler D, Zurbriggen R, Hemphill A. The importance of being parasiticidal… and update on drug development for the treatment of alveolar echinococcosis. FAWPAR. 2019 Mar 14. E00040. doi: 10.1016/j.fawpar.2019.e00040.
2018
Rufener R, Dick L, D'Ascoli L, Ritler D, Hizem A, Wells TNC, Hemphill A, Lundström-Stadelmann B. Repurposing of an old drug: In vitro and in vivo efficacies of Buparvaquone against Echinococcus multilocularis. Int J Parasitol. 2018 Dec. doi: 10.1016/j.ijpddr.2018.10.011.
Wang J, Cardoso R, Marreros N, Müller N, Lundström-Stadelmann B, Siffert M, Vuitton DA, Boué F, Lin R, Wen H, Gottstein B. 2018. Foxp3+ Tregs as a potential target for immunotherapy against primary infection with Echinococcus multilocularis eggs. Infect Immun. 2018 Jul 23. pii: IAI.00542-18. doi: 10.1128/IAI.00542-18.
Rufener R, Ritler D, Zielinski J, Dick L, da Silva ET, da Silva Araujo A, Joekel DE, Czock D, Goepfert C, Marques Moraes A, de Souza MVN, Müller J, Mevissen M, Hemphill A, Lundström-Stadelmann B. 2018. Activity of mefloquine and mefloquine derivatives against Echinococcus multilocularis. International Journal of Parasitology Drugs and Drug Resistance. doi.org/10.1016/j.ijpddr.2018.06.004.
Joekel DE, Lundström-Stadelmann B, Müllhaupt B, Hemphill A, Deplazes P. Evaluation of kinase-inhibitors nilotinib and everolimus against alveolar echinococcosis in vitro and in a mouse model. Experimental Parasitology. 2018. Apr 3. pii: S0014-4894(17)30572-6. doi: 10.1016/j.exppara.2018.04.002.
Liu J, Peirasmaki D, Ma’ayeh S, Lundström-Stadelmann B, Hellman L and SG Svärd. Secreted Giardia intestinalis cysteine proteases disrupt intestinal epithelial cell junctional complexes and degrade chemokines. Virulence. 2018; 9(1): 879–894. doi: 10.1080/21505594.2018.1451284.
Lundström-Stadelmann B. Strategies for the identification of novel treatment options against parasitic diseases. 2018. Habilitation thesis. Vetsuisse Faculty, University of Bern, Switzerland.
2017
Leitsch D, Rout S, Lundström-Stadelmann B, Balmer V, Hehl A and N Müller. Giardia lamblia: missing evidence for a canonical thioredoxin system. Parasitology Open. 2017. doi: 10.1017/pao.2017.16.
Ritler D, Rufener R, Sager H, Bouvier J, Hemphill A and B Lundström-Stadelmann. Development of a movement-based in vitro screening assay for the identification of new anti-cestodal compounds. PLoS Negl Trop Dis. 2017 May 17;11(5):e0005618. doi: 10.1371/journal.pntd.0005618.
Gorgas D, Marreros N, Rufener R, Hemphill A and B Lundström-Stadelmann. To see or not to see: non-invasive imaging for improved readout of drug treatment trials in the murine model of secondary alveolar echinococcosis. Parasitology. 2017 Jun;144(7):937-944. doi: 10.1017/S0031182017000051.
2016
Stadelmann B, Rufener R, Aeschbacher D, Spiliotis M, Gottstein B, Hemphill A. Screening of the Open Source Malaria Box Reveals an Early Lead Compound for the Treatment of Alveolar Echinococcosis. PLoS NTD. 2016. Mar 11;10(3):e0004535. doi: 10.1371/journal.pntd.0004535.
